These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23885696)

  • 21. Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxins.
    Apostolidis A
    Expert Opin Pharmacother; 2011 May; 12(7):1029-39. PubMed ID: 21288184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary management of overactive bladder.
    Smith AL; Wein AJ
    Postgrad Med; 2012 Jan; 124(1):104-16. PubMed ID: 22314120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Overactive Bladder Symptoms After Radical Prostatectomy.
    Peyronnet B; Brucker BM
    Curr Urol Rep; 2018 Oct; 19(12):95. PubMed ID: 30306278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of novel therapies for overactive bladder.
    Mayr CA; Shepherd JP
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):527-35. PubMed ID: 24809616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overactive bladder: diagnosis and management.
    Robinson D; Cardozo L
    Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
    Leong RK; De Wachter SG; van Kerrebroeck PE
    Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing overactive bladder.
    Robinson D; Cardozo L
    Climacteric; 2019 Jun; 22(3):250-256. PubMed ID: 31034265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overactive bladder: treatment options in primary care medicine.
    Sussman DO
    J Am Osteopath Assoc; 2007 Sep; 107(9):379-85. PubMed ID: 17908830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Standard pharmacological treatment and new therapies for overactive bladder].
    Del Popolo G; Mencarini M; Li Marzi V
    Urologia; 2012; 79(1):6-13. PubMed ID: 22344568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Overactive bladder-which treatment when?].
    Pannek J
    Urologe A; 2017 Dec; 56(12):1532-1538. PubMed ID: 29043374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management and future perspectives of overactive bladder (OAB) pharmacotherapy.
    Dobrek Ł; Juszczak K; Wyczółkowski M; Thor PJ
    Acta Pol Pharm; 2011; 68(6):807-21. PubMed ID: 22125944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment?
    Marcelissen T; Cornu JN; Antunes-Lopes T; Geavlete B; Delongchamps NB; Rashid T; Rieken M; Rahnama'i MS
    Eur Urol Focus; 2018 Sep; 4(5):760-767. PubMed ID: 29807823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Nonsurgical Treatments of Overactive Bladder in the United States.
    Brucker BM; Lee RK; Newman DK
    Urology; 2020 Nov; 145():52-59. PubMed ID: 32598892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of cost-effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?
    Giannitsas K; Athanasopoulos A
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):413-23. PubMed ID: 25656409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Devices and Technologies for the Management of Overactive Bladder.
    Guzman-Negron JM; Goldman HB
    Curr Urol Rep; 2017 Oct; 18(12):94. PubMed ID: 29046985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overactive bladder--a practical approach to evaluation and management.
    Madersbacher H
    J Med Liban; 2004; 52(4):220-6. PubMed ID: 16432986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB).
    El-Zawahry A
    Curr Urol Rep; 2019 May; 20(6):33. PubMed ID: 31098731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
    Athanasopoulos A; Chapple C; Fowler C; Gratzke C; Kaplan S; Stief C; Tubaro A
    Eur Urol; 2011 Jul; 60(1):94-105. PubMed ID: 21497434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Bywater M; Kessler TM
    Praxis (Bern 1994); 2017; 106(21):1175-1181. PubMed ID: 29041854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.